Apellis Pharmaceuticals Inc (APLS) Insider Trading
- $23,844,337.28
- $105,554,398.32
- March 17, 2025
- Alec Machiels
Trader Name | Date | Title | Amount | Price | Type | Total Value |
---|---|---|---|---|---|---|
Jan. 14, 2022 | Insider | 375 | $40.56 | Sell | $15,210.00 | |
Dec. 27, 2021 | General Counsel | 1,200 | $48.50 | Sell | $58,200.00 | |
Dec. 22, 2021 | General Counsel | 10,571 | $47.81 | Sell | $505,399.51 | |
Nov. 18, 2021 | Major Shareholder | 250,000 | $40.00 | Buy | $10,000,000.00 | |
Nov. 1, 2021 | Insider | 625 | $30.70 | Sell | $19,187.50 | |
Oct. 14, 2021 | Insider | 750 | $34.57 | Sell | $25,927.50 | |
July 21, 2021 | SVP | 1,000 | $65.00 | Sell | $65,000.00 | |
July 15, 2021 | Director | 2,500 | $62.30 | Sell | $155,750.00 | |
July 15, 2021 | SVP | 1,000 | $62.30 | Sell | $62,300.00 | |
July 14, 2021 | Insider | 500 | $64.68 | Sell | $32,340.00 | |
July 8, 2021 | Insider | 250 | $65.68 | Sell | $16,420.00 | |
June 24, 2021 | Insider | 6,250 | $65.61 | Sell | $410,062.50 | |
June 15, 2021 | SVP | 4,000 | $64.96 | Sell | $259,840.00 | |
June 15, 2021 | Director | 2,500 | $64.83 | Sell | $162,075.00 | |
June 14, 2021 | Insider | 500 | $61.84 | Sell | $30,920.00 | |
June 11, 2021 | VP | 1,000 | $61.55 | Sell | $61,550.00 | |
June 10, 2021 | Insider | 3,417 | $60.00 | Sell | $205,020.00 | |
June 1, 2021 | VP | 1,000 | $56.40 | Sell | $56,400.00 | |
May 20, 2021 | Director | 5,773 | $48.10 | Sell | $277,681.30 | |
May 18, 2021 | Director | 149,488 | $52.85 | Sell | $7,900,440.80 | |
May 18, 2021 | SVP | 2,000 | $55.00 | Sell | $110,000.00 | |
April 30, 2021 | VP | 1,000 | $50.00 | Sell | $50,000.00 | |
April 23, 2021 | Insider | 6,250 | $46.13 | Sell | $288,312.50 | |
April 21, 2021 | Director | 2,500 | $45.76 | Sell | $114,400.00 | |
April 14, 2021 | Insider | 500 | $42.82 | Sell | $21,410.00 | |
April 1, 2021 | Insider | 600 | $43.41 | Sell | $26,046.00 | |
March 15, 2021 | Insider | 500 | $46.77 | Sell | $23,385.00 | |
March 15, 2021 | Director | 2,500 | $46.77 | Sell | $116,925.00 | |
March 10, 2021 | Insider | 6,250 | $50.74 | Sell | $317,125.00 | |
March 5, 2021 | Insider | 5,000 | $48.62 | Sell | $243,100.00 | |
Feb. 9, 2021 | VP | 2,000 | $50.00 | Sell | $100,000.00 | |
Jan. 15, 2021 | Director | 2,500 | $53.15 | Sell | $132,875.00 | |
Jan. 14, 2021 | Insider | 4,000 | $51.99 | Sell | $207,960.00 | |
Dec. 15, 2020 | CEO | 5,000 | $52.16 | Sell | $260,800.00 | |
Dec. 14, 2020 | General Counsel | 18,333 | $50.94 | Sell | $933,883.02 | |
Dec. 14, 2020 | Director | 25,000 | $54.67 | Sell | $1,366,750.00 | |
Dec. 7, 2020 | Director | 25,000 | $50.59 | Sell | $1,264,750.00 | |
Dec. 4, 2020 | VP | 18,000 | $50.00 | Sell | $900,000.00 | |
Dec. 4, 2020 | Director | 6,436 | $50.26 | Sell | $323,473.36 | |
Dec. 1, 2020 | Insider | 600 | $48.25 | Sell | $28,950.00 | |
Nov. 16, 2020 | Director | 2,500 | $39.38 | Sell | $98,450.00 | |
Nov. 16, 2020 | CEO | 5,000 | $39.38 | Sell | $196,900.00 | |
Nov. 2, 2020 | Insider | 600 | $31.09 | Sell | $18,654.00 | |
Oct. 15, 2020 | Director | 2,500 | $35.00 | Sell | $87,500.00 | |
Oct. 15, 2020 | CEO | 5,000 | $34.46 | Sell | $172,300.00 | |
Oct. 7, 2020 | Director | 7,500 | $35.00 | Sell | $262,500.00 | |
Oct. 7, 2020 | Insider | 12,000 | $35.00 | Sell | $420,000.00 | |
Sept. 15, 2020 | CEO | 5,000 | $30.96 | Sell | $154,800.00 | |
Sept. 1, 2020 | Insider | 600 | $31.58 | Sell | $18,948.00 | |
Aug. 20, 2020 | CEO | 3,457 | $30.00 | Sell | $103,710.00 |
Insiders are both buying and selling Apellis Pharmaceuticals Inc stock.
The insider traders at Apellis Pharmaceuticals Inc are: Alec Machiels, Cedric Francois, Federico Grossi, Pascal Deschatelets, David O Watson, A. Sinclair Dunlop, Mark Jeffrey Delong, Timothy Eugene Sullivan, Adam J Townsend, James George Chopas, Lukas Scheibler, Jeffrey Eisele, Nur Nicholson, Nicole D Perry, Morningside Venture Investment, Karen Lewis, Caroline Baumal, Machiels Alec, Global Strategic Fund I Venbio, Deschatelets Pascal, Victoria L Brown, and Victoria L. Brown
The most active insider trader at Apellis Pharmaceuticals Inc is Alec Machiels with 30 trades.
Cedric Francois has sold the most Apellis Pharmaceuticals Inc stock with a total value of $35,626,981.58.
Morningside Venture Investment has bought the most Apellis Pharmaceuticals Inc stock with a total value of $31,651,764.04.
The most recent insider trade for Apellis Pharmaceuticals Inc was on March 17, 2025.
The single biggest insider buy for Apellis Pharmaceuticals Inc was from Morningside Venture Investment with a total value of $10,000,000.00 on Nov. 18, 2021.
The single biggest insider sell for Apellis Pharmaceuticals Inc was from Cedric Francois with a total value of $16,027,500.00 on March 1, 2024.